Rutland Herald

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients

Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular ...
Healio

Patients report high satisfaction with uncorrected distance vision with PureSee IOL

Please provide your email address to receive an email when new articles are posted on . A study compared the Tecnis PureSee extended depth of focus IOL and a Tecnis ...
PharmiWeb

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens ...
Healio

PureSee IOL demonstrates quality distance, intermediate vision

Please provide your email address to receive an email when new articles are posted on . The real-world observational study included 293 patients. The lens is designed to extend range of vision, ...
Yahoo Finance

Johnson & Johnson (JNJ) Valuation Check As TECNIS PureSee IOL Data Take Center Stage

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...